(Q43477917)

23 November 2017

Does osteoporosis therapy invalidate FRAX for fracture prediction? (English)

1 reference

23 November 2017

0 references

1 reference

1

1 reference

23 November 2017

5

Eugene McCloskey

1 reference

23 November 2017

4

Anders Oden

1 reference

23 November 2017

6

John A Kanis

1 reference

23 November 2017

3

Helena Johansson

1 reference

PubMed ID

22392538

Manitoba Bone Density Program

23 November 2017

series ordinal

7

object named as

Manitoba Bone Density Program

1 reference

23 November 2017

Lisa M Lix

2

1 reference

23 November 2017

1 June 2012

1 reference

Journal of Bone and Mineral Research

23 November 2017

1 reference

23 November 2017

27

1 reference

23 November 2017

6

1 reference

23 November 2017

1243-1251

1 reference

Burden of osteoporosis and fractures

23 November 2017

1 reference

Quality of life in patients with osteoporosis

21 January 2018

1 reference

Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).

21 January 2018

1 reference

Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis

21 January 2018

1 reference

2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary

21 January 2018

1 reference

Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis

21 January 2018

1 reference

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women.

21 January 2018

1 reference

Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA.

21 January 2018

1 reference

A revised clinician's guide to the prevention and treatment of osteoporosis.

21 January 2018

1 reference

Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.

21 January 2018

1 reference

Interpretation and use of FRAX in clinical practice

21 January 2018

1 reference

Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs

21 January 2018

1 reference

Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?

21 January 2018

1 reference

A population-based study of osteoporosis testing and treatment following introduction of a new bone densitometry service

21 January 2018

1 reference

Construction and validation of a population-based bone densitometry database

21 January 2018

1 reference

Recalculation of the NHANES database SD improves T-score agreement and reduces osteoporosis prevalence

21 January 2018

1 reference

A reference standard for the description of osteoporosis

21 January 2018

1 reference

Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts.

21 January 2018

1 reference

Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos

21 January 2018

1 reference

The potential impact of new National Osteoporosis Foundation guidance on treatment patterns

21 January 2018

1 reference

Updated fracture incidence rates for the US version of FRAX.

21 January 2018

1 reference

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

A note on competing risks in survival data analysis

21 January 2018

1 reference

Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies

21 January 2018

1 reference

Effectiveness of bisphosphonate therapy in a community setting

21 January 2018

1 reference

Identification and validation of vertebral compression fractures using administrative claims data

21 January 2018

1 reference

Algorithms can be used to identify fragility fracture cases in physician-claims databases

21 January 2018

1 reference

Ten-year fracture probability identifies women who will benefit from clodronate therapy--additional results from a double-blind, placebo-controlled randomised study

21 January 2018

1 reference

Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.

21 January 2018

1 reference

A meta-analysis of the efficacy of raloxifene on all clinical and vertebral fractures and its dependency on FRAX.

21 January 2018

1 reference

A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX(®).

21 January 2018

1 reference

Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment

21 January 2018

1 reference

Bone Density Monitoring With the Total Hip Site

21 January 2018

1 reference

Effectiveness of Bone Density Measurement for Predicting Osteoporotic Fractures in Clinical Practice

21 January 2018

1 reference

Independent clinical validation of a Canadian FRAX tool: Fracture prediction and model calibration

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JBMR.1582

1 reference

23 November 2017

1 reference

PubMed ID

22392538